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ABSTRACT
Alternative splicing has been associated with
increased evolutionary changes and with recent
exon creation or loss. The addition of a new exon
can be explained by its inclusion in only a fraction
of the transcripts leaving the original form intact and
giving to the new form the possibility to evolve
independently but the exon loss phenomenon is
less clear. To explore the mechanism that could be
involved in CFTR exon 12 lower splicing efficiency
in primates, we have analyzed the effect of multiple
synonymous variations. Random patterns of synon-
ymous variations were created in CFTR exon12
and the majority of them induced exon inclusion,
suggesting a suboptimal splicing efficiency of the
human gene. In addition, the effect of each single
synonymous substitution on splicing is strongly
dependent on the exonic context and does not
correlate with available in silico exon splicing pre-
diction programs. We propose that casual synony-
mous substitutions may lead to a reduced splicing
efficiency that can result in a variable proportion of
exon loss. If this phenomenon happens in in-frame
exons and to an extent tolerated by the cells it can
have an important evolutionary effect since it may
generate a substrate for natural selection of new
splicing isoforms.
INTRODUCTION
Pre-mRNA splicing is a complex mechanism that relies on
the correct identiﬁcation of protein-coding sequences
(exons), on the transcribed RNA, from the more abundant,
non-coding sequences (introns). This identiﬁcation requires
not only the presence of the ‘core’ splicing recognition
features such as the 50- and 30-splice sites, branch-point
sequences, and polypyrimidine tracts but is also modulated
by additional cis-acting elements (1). These elements are
localized either within the coding sequence or close to introns
and may enhance or antagonize RNA processing. (2–4).
Alternative pre-mRNA splicing, a pervasive feature in mam-
malian genomes, generates multiple transcripts from a single
pre-mRNA and is a fundamental mechanism for the regula-
tion of gene expression and the generation of proteome
diversity. From an evolutionary point of view, alternative
splicing is associated with a large increase in the frequency
of recent creation and/or loss of exons, and it has the potential
ability to generate minor, species-speciﬁc alternative spliced
exons (5). In the case of the generation of new alternative
spliced forms the new exon has been viewed as an internal
paralog to its own gene in which a new function can poten-
tially evolve without disrupting the original function of the
gene. In humans one possible mechanism to generate new
exons is the inclusion of parts of Alu sequences into mature -
mRNAs. These mobile elements can provide preformed
splice sites that can be tested during the evolution (6,7) and
in fact internal exons that contain an Alu sequence are predo-
minantly, if not exclusively, alternatively spliced (8). On the
other hand the mechanism that leads to a reduced splicing
efﬁciency in constitutively included exons and the signiﬁc-
ance of the exon loss is less clear.
Exonic splicing regulatory elements contribute signiﬁc-
antly to constitutive and alternative splicing regulation
(1,2,9). These are highly degenerated RNA sequences that
interact with several classes of positive and negative splicing
trans-acting regulatory factors. Exonic splicing regulatory
elements overlap with the amino acid code and are found
in both pre-mRNAs that are constitutively (10,11) and
alternatively spliced (1,12). Their importance in pre-mRNA
splicing is relevant in ﬁelds as diverse as clinical genetics
and molecular evolution. In fact, extensive evidence indicates
that exonic point mutations may affect pre-mRNA splicing in
several human disease genes (2,4,13–23). In particular,
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splicing regulatory elements because they may affect the spli-
cing efﬁciency without theoretically changing the protein
sequence. In several cases they may have pathological conse-
quences (2,4,24). To identify the ‘splicing code’ hidden in
exonic sequence and thus to predict the splicing phenotype
of exonic mutations in human genes, several in silico pro-
grams have been developed (3,9,25,26), but few studies
have systematically evaluated their reliability in clinical
genetics. On the other hand, exonic splicing enhancers are
widely distributed among metazoans from ﬂies to humans
(1), they have been reported also in yeast (27) and suggested
to play a role in species-speciﬁc alternative splicing regula-
tion (5). However, the effect of evolutionary related exonic
nucleotide substitutions on the splicing efﬁciency and on
the generation of new alternative splicing events is largely
unexplored.
The CFTR exon 12 show reduced splicing efﬁciency in the
primates (28–30) and its length being multiple of three, its
skipping maintains in-frame the ﬁnal protein. The alternative
spliced form has up to now not been ascribed any functional
role. Even if complete skipping causes severe classical cystic
ﬁbrosis (30,31), the functional signiﬁcance and the mechan-
ism that have generated this alternative splicing with partial
skipping in the human lineage (between 5 and 30% in humans
in vivo) (30,32) is unknown. Interestingly, the evolutionary
differences in CFTR exon 12 in most mammals are mainly
restricted to synonymous substitutions which are distributed
in the entire exon length at 14 different sites (28). The only
exception is found in the rodent lineage that has additional
four non-synonymous substitutions (28). In the human
CFTR exon 12, we have previously analyzed the exon splic-
ing efﬁciency of several single synonymous changes in the
central region of the exon (28). As  25% of them negatively
affect the splicing process inducing exon skipping, these sites
cannot evolve freely and are signiﬁcantly constrained by
splicing requirements, a fact that is supported by recent stat-
istical and large scale genome comparative evidences (24,33).
Synonymous substitutions in CFTR exon 12 might affect
RNA secondary structure as previously suggested by statist-
ical analysis (34), a possibility that needs additional experi-
mental validation.
In this paper we have evaluated the functional role of mul-
tiple synonymous substitutions in order to understand why the
CFTR exon 12 has a lineage-speciﬁc alternative splicing and
to get more insight on the underlying regulatory mechanism.
The effect of multiple random synonymous substitutions on
the human CFTR exon 12 splicing pattern indicate that its
splicing efﬁciency is the combinatorial result of single muta-
tions and that the synonymous sites in the human gene have
unexpectedly evolved toward a reduced splicing efﬁciency.
This reduced splicing efﬁciency may be simply a background
noise level tolerated by the cells but in turn generates a
substrate for natural selection of new splicing isoforms.
MATERIALS AND METHODS
Hybrid minigene constructs
By PCR-mediated site-directed mutagenesis with ex12-Xba
Rev 50-TTCTGTTAAAACATCTAGATATCC-30 and exon
12-Xba Dir 50-ACTCTCCTTTTGGATATCTAGATG-30 we
introduced in the WTB minigene (22) a single 52T substitu-
tion that creates a unique XbaI restriction site. The resulting
minigene (pTBCFex12 52T) was digested with AccI and
XbaI, dephosphorylated and the corresponding exonic seq-
uence between positions 13 and 52 replaced with two pairs
of degenerated single stranded 50-phosphorylated oligomers
that contained a randomized 13-degenerated codons core










Each annealed oligonucleotide duplex (10 mg each) was
ligated into the pTBCFex12 52T transformed into the
DH5a strain of Escherichia coli. Random transformed colo-
nies were collected, sequenced and then individually ana-
lyzed for splicing efﬁciency. Out of 22 single synonymous
substitutions between positions 13 and 52 in the CFTR exon
12, 19 have been previously reported (28). The missing three
mutations (31g, 46tc and 49c) were introduced in the previ-
ously described WTB minigene (22) between the AccI and
BamHI sites, which were substituted with the appropriate
AccI–BamHI cassettes created by PCR-mediated site-
directed mutagenesis. The same strategy was used for the
preparation of the minigenes reported in Figure 4. The oligo-
nucleotides used for PCR-mediated mutagenesis are available
upon request. All mutations were conﬁrmed by sequencing.
Analysis of the hybrid minigene expression
Transient transfection of Hep3B cells, RNA extraction,
reverse transcription RT–PCR, and quantitation of PCR pro-
ducts were done as described previously (22). PCRs were
optimized to remain in the exponential range of ampliﬁcation
and products were routinely fractionated in 1.5% (w/v) agar-
ose gel. For quantitation of the PCR,
32dCTP was included
in the PCR mixture, the products loaded on 5% denaturing
polyacrylamide–8 M urea gel, dried and exposed to a Cyclone
Instant Imager. The counts of each splicing band were cor-
rected by the number of C/G present in the PCR-product
sequence.
Statistical analysis and in silico predictions
Statistical analysis was performed with StatView program
and data were evaluated with nonparametric Kruskal Wallis
and Mann Whitney tests. In silico analysis was performed
using the following web-based resources, ESEﬁnder (http://
rulai.cshl.edu/tools/ESE/) (25), RESCUE-ESE (http://genes.
mit.edu/burgelab/rescue-ese/) (3), and PESX (http://cubweb.
biology.columbia.edu/pesx/) (26). The threshold score for
the enhancer or silencer motifs were set to the values sug-
gested by the programs. The relationship between the number
of splicing regulatory motifs and the percentage of exon
inclusion was evaluated with linear regression using StatView
program.
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The composition of synonymous site in human CFTR
exon 12 is suboptimal for splicing efficiency
We have followed our earlier observations of the effect of site-
directed mutants selected from the evolutionary divergences in
mammals with random mutagenesis to explore the limits of the
exon sequence variability. We have replaced the (wild-type)
WT CFTR exon 12 sequence between positions 13 and 52
with two degenerated oligonucleotides pairs that differ at con-
served Leu and Ser codons (Figure 1B). To facilitate cloning
procedures the minigene contained a XbaI site that was
inserted in position 52 changing the C with a T (Figure 1A)
and the I and II oligomers ligated between the AccI and
XbaI sites. Single clones derived from the ligations were iso-
lated, sequenced and analyzed for splicing efﬁciency. We have
evaluated a total number of 25 and 17 variants randomly selec-
ted from the I and II sequences, respectively. Compared with
WT the I and II mutants showed a mean of 7.6 and 15.6 synon-
ymous substitutions, respectively. Among the total number of
42 random sequences, 22 (53%) showed complete exon inclu-
sion, 4 (9%) severe exon skipping (<15% of exon inclusion)
and intermediate levels were observed in 16 (38%) sequences.
Considering the 25 clones derived for the synonymous
changes generated with the I oligonucleotide, 13 (52%), 8
(32%) and 4 (16%) variants showed complete, intermediate
and low exon inclusion levels, respectively. Interestingly,
only one clone showed complete exon skipping (I.25), whereas
no minigene variants with low percentages of exon inclusion
(<15%) were observed in the II group (Figure 2). The creation
of the XbaI site used to facilitate cloning of the oligos had a
conspicuous negative effect on the splicing pattern as expected
from our previous work (28). On the other hand most of
synonymous changes produce a signiﬁcant improvement not
only of the defective splicing caused by the 52 C to T change
(XbaI site creation) but also relative to the WT pattern
(Figure 1C). To further explore its potential confounding effect
we restored the WT 52C in selected clones derived from the
I oligo. Eight clones, indicated with a (C) in Figure 2, from
the group with high, intermediate and low exon inclusion
were mutated to 52C and analyzed for splicing efﬁciency in
transfection experiments. This analysis revealed that the 52
T to C mutation did not affect the splicing pattern in clones
with complete exon inclusion (I.1, I.5, I.8 and I.13) and with
complete exon skipping (I.25) (Figure 2). On the other three
intermediate clones (I.18, I.19 and I.23) this T to C substitution
increased the percentage of exon inclusion. Overall the results
indicate that the 52T variant used to facilitate cloning does not
affect the ﬁnal results and that the majority of random multiple
synonymous changes enhance CFTR exon 12 inclusion.
Correlation between single and multiple synonymous
substitutions on the splicing efficiency
We have previously reported the effect of 19 out of 22 single
synonymous substitutions between positions 13 and 52 on the
exon 12 splicing efﬁciency (28). To compare the relationship
between the multiple at the single synonymous substitutions
we now have evaluated the three lacking variants and the
complete analysis is shown in Figure 3A and B. Compared
with the WT basal splicing efﬁciency each synonymous sub-
stitution can induce exon skipping, exon inclusion or have no
effect. Out of 22 single synonymous substitutions, the major-
ity (13) have a positive effect on splicing-inducing exon
inclusion, 7 induce exon skipping and 7 did not affect the
splicing pattern (Figure 3A). As the majority of substitutions
preferentially induce exon inclusion we tested if the splicing
pattern observed in multiple substitutions can be the result of
the effect of each single substitution. To analyze the relation-
ship between the single and multiple synonymous substi-
tutions each change was classiﬁed as positive, negative or
neutral according to its effect on splicing; the I minigenes
with multiple changes were also separated in three groups
Figure 1. Combined effect of multiple random synonymous substitutions on
CFTR exon 12 splicing pattern. (A) Schematic representation of the CFTR
hybrid minigene used in transient transfection assay showing the location of
the two restriction sites in exon 12 that were used for cloning the I and II
degenerated oligonucleotides. Exonic and intronic sequences are shown as
boxes and lines, respectively, the hatched box corresponds to the substituted
sequence and the arrows show the specific oligonucleotides used in RT–PCR
analysis. The two alternative splicing possibilities are indicated as dotted
lines. The XbaI site was created by site-directed mutagenesis and corresponds
to 52T synonymous substitution. (B) Nucleotide composition of part of the
human CFTR exon 12 between the AccI and XbaI sites. Third nucleotide
positions are numbered according to their location in the exon. The two 14-
degenerated codons oligonucleotides I and II (II differs to I at conserved Leu
and Ser codons, which are underlined) are indicated. These oligomers were
cloned in the CFTR exon 12 to create random changes at synonymous sites
between the exonic positions 13 and 52. (C) Effect of multiple random
synonymous substitutions on splicing efficiency. Representative samples of
the CFTR exon 12 minigenes derived from the degenerated oligonucleotides I
are shown and their sequences are represented in Figure 2. Minigenes were
transfected in Hep3B cells and analyzed for splicing efficiency. The
percentages of exon inclusion are reported at the bottom of each lane and
are the mean of three independent experiments done in duplicate. The effect
of the multiple random synonymous substitutions is compared with the WT and
the CFXba+ minigenes. The exon 12 inclusion and skipping forms are indicated.
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low that correspond to 100, 99–50 and 50–0%, respectively.
In each group the number of synonymous differences that
induce exon inclusion or exclusion were recorded and ana-
lyzed for statistical signiﬁcance. The number of enhancing
changes decreased progressively with the reduction of the
efﬁciency of splicing (Figure 3C). This difference was statis-
tically signiﬁcant between the three groups and between the
high and low efﬁciency groups. On the other hand, a higher
number of silencing changes were found in the low efﬁciency
group and in this case a signiﬁcant correlation was evident
between the high and low efﬁciency groups (Figure 3C).
The context determines the exon splicing efficiency
of synonymous substitutions
To test the importance of the context in determining the effect
on splicing of single nucleotide substitutions we focus our
attention on the G to A substitutions at position 34 and the
T to C mutation at position 52, two mutations that induce
signiﬁcant exon skipping in the WT minigene (Figure 3A).
The effect of these substitution on splicing was analyzed in
three different contexts derived from the I.1, I.18 and I.25
minigenes with random CFTR exon 12 multiple synonymous
substitutions (Figure 4). Strikingly, the 34G to A substitution
may have no effect on exon inclusion (compare lanes 4
Figure 2. Effect of CFTR exon 12 random multiple synonymous substitutions on the splicing efficiency. The two 13-degenerated codons oligonucleotides
I and II were cloned in the CFTR exon 12 to create random changes at synonymous sites between the exonic positions 13 and 52. Resulting hybrid minigenes
(I.1 to I.25 and II.1 to II.17) were then isolated and individually analyzed for splicing efficiency. The position of the mutations relative to the wild-type (CFWT)
exon is shown at the top and synonymous mutations are in bold in comparison to human sequence. Number on the right of each sequence indicates the percentage
of exon inclusion as determined by minigene splicing assay and is the mean of three independent experiments done in duplicate. In some clones derived from
degenerated oligonucleotide I (indicated with a additional (C)) we changed the T52 to the wild-type C52 and the resulting percentage of exon inclusion is
indicated in parenthesis on the right. The clones with the asterisks I.1, I.18 and I.25 were selected for subsequent experiments shown in Figure 4. Compared with
WT sequence the I mutants showed a mean of 7.6 synonymous substitutions, the II mutants 15.6.
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and 7) or complete exon skipping (compare lanes 8 and 9)
(Figure 4B). The 52T to C substitution did not affect the com-
plete exon inclusion in three contexts: I.18 (lanes 14 and 15),
I.1C (lane 18 and 19) and I.18+G (lanes 20 and 21) but
increase the exon splicing efﬁciency in I.25+G (lanes 16
and 17, from 100 to 80%) and in I.1+A (lanes 12 and 13,
from 55 to 0%). In the context of the exon already completely
excluded (I.25), this substitution did not affect splicing
(compare lanes 10 and 11). These results clearly show that
the context where a synonymous mutation occur determine
its effect on the splicing pattern.
Correlation between the splicing efficiency of
synonymous substitutions and the in silico predictions
We tested if the exon inclusion efﬁciency resulting from 22
single and 55 multiple synonymous substitutions is dependent
on predictable Exonic Splicing regulatory sequences. The
number of predicted sites using ESE ﬁnder (25), RESCUE-
ESE (3) and PESX (26) programs were plotted against the
percentage of exon inclusion and the results are shown in
Figure 5. No signiﬁcant correlation was observed between
the number of predicted sites and the splicing efﬁciency for
both the single and double mutants. In addition, the combined
evaluation of the effect of both putative exonic splicing silen-
cer (PESS) and putative exonic splicing enhancers (PESE),
calculated as the difference between them, did not show sig-
niﬁcant correlation (data not shown).
DISCUSSION
Alternative splicing has been associated with increased evo-
lutionary changes and in particular with a large increase in
frequency of recent exon creation and/or loss (5). The addi-
tion of a new exon to a gene, the so called exonization pro-
cess, might result in its inclusion in only a fraction of the
transcripts, leaving the original form intact and giving to
the new form the possibility to evolve independently. In
humans intronic Alu repeats can turn into new alternative
exons by providing potential splice sites (6,7). In this
Figure 3. The effect of multiple synonymous substitutions on splicing correlates with the sum of the effect of each single substitution. (A) Nucleotide
composition of part of the human CFTR exon 12 between the AccI and XbaI sites. Third nucleotide positions are numbered according to their location in the
exon. The 22 possible single synonymous changes are shown. According to their individual effect on splicing in WT context, the synonymous substitutions were
classified as positive, (mutations that induce exon inclusion, underlined) negative (exon skipping, boxed ) or neutral (no effect in black). (B) Representative RT–
PCR products from transfection experiments showing the effect of single synonymous substitutions. The 31g, 46c and 49c mutations, not tested previously (28),
are compared with WT and other selected mutants. The exon 12 inclusion and skipping forms are indicated. The percentages of exon inclusion are reported at the
bottom of each lane and are the mean of three independent experiments done in duplicate. (C) Correlation between splicing efficiency of single and multiple
synonymous substitutions. The clones shown in Figure 2 with random multiple substitutions originated from the I oligonucleotides were grouped according to
their splicing efficiency: high, intermediate and low corresponding to 100, 99–50 and 50–0% of splicing, respectively. For each group the number of positive or
negative synonymous substitutions were calculated (y axis) and analyzed for statistical significance (*, P < 0.05 between the three different groups), (**, P < 0.05
between the high ad low efficiency groups).
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process focusing on the variability of exonic splicing regula-
tory elements in the CFTR exon 12 at synonymous sites. As
per deﬁnition, synonymous mutations do not change the pro-
tein, but they may affect splicing regulatory elements and
modify the percentage of exon inclusion, hence having an
important effect on human disease as well as in the creation
of new alternative splicing isoforms. We have previously
observed that single nucleotide substitutions at synonymous
sites of the human exon can signiﬁcantly affect its splicing
pattern inducing both exon skipping or inclusion (28). We
show here that multiple random synonymous substitutions
preferentially increase the exon inclusion indicating that the
composition of the human CFTR exon 12 is suboptimal for
splicing efﬁciency (Figure 2). This effect on splicing was
studied further by analyzing the correlation between single
and multiple synonymous substitutions. The analysis of
each single nucleotide variation showed that the majority of
Figure 4. The context determines the exon splicing efficiency of synonymous substitutions. Significant sequence differences among the minigene constructs are
highlighted Percentages of exon inclusion, determined by splicing assay, are indicated on the right. (A) Sequence comparison among I.1C, I.18C and I.25C
minigenes. Significant sequence differences among the minigenes are highlighted and correspond to the T1 tract (A13, C16, C19 and C22), to position 34( Go r
A) and at the T2 tract (C43 and A49). Compared with I.25C, I.18C had changes at T1 tract sequence (A13, C16, C19 and C22) and T2 tract (C43 and A49)
whereas A1C showed differences at G34 and T2 (shown in bold and highlighted). (B) Splicing effect of the G to A substitution in position 34 in the three different
contexts derived from I.1C, I.18C and I.25C. The G to A substitution at position 34 did not affect splicing in I.18C (compare I.18C+G with I.18C), caused partial
exon skipping in I.1C (compare I.1C with I.1C+A) and complete exon skipping in I.25 (compare I.25C+G with I.25C). (C) Splicing effect of the T to C
substitution in position 52 in three different contexts derived from I.1C, I.18C and I.25C. The T to C substitution in position 52 did not affect splicing in I.25 and
I.18 context but induce partial exon inclusion in the A1 context. (D) Splicing effect of the T to C substitution in position 52 in three different contexts in the
presence of the G to A substitution in position 34. In this case, the T to C substitution in position 52 did not affect splicing in I.1 and I.18 context but induce
partial exon inclusion in the I.25 context. (E) RT–PCR products of transfection experiments. The different minigenes were transfected in Hep3B cells and
analyzed for splicing efficiency. The exon 12 inclusion and skipping forms are indicated.
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(13 and 7, respectively) (Figure 3) indicating that the ﬁnal
exon splicing efﬁciency is due to some extent to the com-
bined additive effect of the single synonymous changes.
Since the alternatively spliced CFTR exon 12 minus form
does not seem to have a clear functional role, its exon skip-
ping might be simply ascribed to aberrant splicing generated
by the ‘noise’ of the splicing machinery induced fortuitously
by the synonymous substitutions (35). However, the aberrant
splicing ‘noise’ might play a role in evolution by generating
new alternative protein isoforms to be eventually selected. In
fact our results provide a possible explanation for the
previously reported (5) large increase in frequency of recent
exon loss during evolution. Successive multiple synonymous
mutations can induce partial skipping of a constitutively
included in-frame exon. This will result in a slightly reduced
production of the original protein and in the generation of a
new alternatively spliced isoform. This situation ensures pre-
servation of function and the new isoform without the exon
can be evolutionary selected. Interestingly, new minor and
not evolutionary conserved alternatively spliced exons are
frequently reported in several disease-causing genes like
NF1, CFTR and BRCA1. These events may result from the
fortuitous insertion of negative splicing regulatory elements
due to retrotransposition, as previously found in the CFTR
exon 9 (36), or due to changes in exonic splicing regulatory
elements. It remains to be determined how frequently species-
speciﬁc new alternative splicing forms generated by substitu-
tions at synonymous site are present in the human genome.
To explore the underlying splicing regulatory mechanism
affected by multiple synonymous substitutions we have
used available in silico programs that identify exonic splicing
regulatory elements. With  70 mutants tested this is to our
knowledge the largest analysis on a single exon that compares
the splicing effect of multiple mutations in their original con-
text with in silico predictions. The fact that the number of
predicted exonic splicing enhancers and silencer motifs
does not correlate with the splicing efﬁciency (Figure 5)
indicates that the in silico programs are not useful to predict
the effect of multiple mutations at least in the case of CFTR
exon 12. This can be due to the fact that the available predic-
tion programs deal with just a subgroup of splicing regulatory
elements, which are not well represented in the CFTR exon
12. Since these programs are widely used in clinical genetics,
it seems useful that their predictions should be experimentally
validated in appropriate splicing assays that take into account
the original gene context as far as possible. Furthermore,
discrete sequences may have a strong context-dependent
effect and can function as enhancer or silencer depending
on the exonic context (9,12). On the other hand, the correla-
tion between the effect of single and multiple synonymous
substitutions and their context-dependent effect (Figure 3)
suggests the presence of multiple overlapping splicing regula-
tory elements distributed along the entire CFTR exon 12,
with both enhancer and silencer functions that are not really
considered in the currently available prediction programs. At
present their properties are difﬁcult to explore by means of
in silico analysis. It is possible that the entire sequence of
the CFTR exon 12 is entirely made up by Composite Exonic
Regulatory Element of Splicing (CERES) as previously sug-
gested (22). The composite nature of these elements may
result from the binding of multiple antagonistic splicing
regulatory factors with different afﬁnity that may be also
modulated by RNA secondary structure.
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Figure 5. Number of predicted exonic splicing enhancers motifs do not correlate with splicing efficiency. The percentages of exon inclusion detected by splicing
assay were compared with the number of predicted exonic splicing regulatory motifs. The analysis includes 22 minigenes with a single substitution, 6 with
multiple synonymous substitutions (shown in Figure 4) and 49 minigenes derived from random multiple synonymous substitutions (shown in Figure 2). Splicing
regulatory motifs were predicted using RESCUE-ESE (3), ESE finder (19) and PEXS (26) programs.
612 Nucleic Acids Research, 2007, Vol. 35, No. 2REFERENCES
1. Black,D.L. (2003) Mechanisms of alternative pre-messenger RNA
splicing. Ann. Rev. Biochem., 72, 291–336.
2. Cartegni,L., Chew,S.L. and Krainer,A.R. (2002) Listening to silence
and understanding nonsense: exonic mutations that affect splicing.
Nature Rev. Genet., 3, 285–298.
3. Fairbrother,W.G., Yeh,R.F., Sharp,P.A. and Burge,C.B. (2002)
Predictive identification of exonic splicing enhancers in human genes.
Science, 297, 1007–1013.
4. Pagani,F. and Baralle,F.E. (2004) Genomic variants in exons and
introns: identifying the splicing spoilers. Nature Rev. Genet., 5,
389–396.
5. Modrek,B. and Lee,C.J. (2003) Alternative splicing in the human,
mouse and rat genomes is associated with an increased frequency of
exon creation and/or loss. Nat Genet, 34, 177–180.
6. Lev-Maor,G., Sorek,R., Shomron,N. and Ast,G. (2003) The birth of an
alternatively spliced exon: 30 splice-site selection in Alu exons.
Science, 300, 1288–1291.
7. Sorek,R., Lev-Maor,G., Reznik,M., Dagan,T., Belinky,F., Graur,D. and
Ast,G. (2004) Minimal conditions for exonization of intronic
sequences: 50 splice site formation in alu exons. Mol. Cell, 14,
221–231.
8. Sorek,R., Ast,G. and Graur,D. (2002) Alu-containing exons are
alternatively spliced. Genome Res., 12, 1060–1067.
9. Goren,A., Ram,O., Amit,M., Keren,H., Lev-Maor,G., Vig,I., Pupko,T.
and Ast,G. (2006) Comparative analysis identifies exonic splicing
regulatory sequences-the complex definition of enhancers and
silencers. Mol. Cell, 22, 769–781.
10. Mayeda,A., Screaton,G.R., Chandler,S.D., Fu,X.D. and Krainer,A.R.
(1999) Substrate specificities of SR proteins in constitutive splicing are
determined by their RNA recognition motifs and composite pre-mRNA
exonic elements. Mol. Cell. Biol, 19, 1853–1863.
11. Schaal,T.D. and Maniatis,T. (1999) Multiple distinct splicing enhancers
in the protein-coding sequences of a constitutively spliced pre-mRNA.
Mol. Cell. Biol, 19, 261–273.
12. Muro,A.F., Caputi,M., Pariyarath,R., Pagani,F., Buratti,E. and
Baralle,F.E. (1999) Regulation of fibronectin EDA exon alternative
splicing: possible role of RNA secondary structure for enhancer
display. Mol. Cell. Biol, 19, 2657–2671.
13. Faustino,N.A. and Cooper,T.A. (2003) Pre-mRNA splicing and human
disease. Genes Dev., 17, 419–437.
14. Garcia-Blanco,M.A., Baraniak,A.P. and Lasda,E.L. (2004) Alternative
splicing in disease and therapy. Nat Biotechnol., 22, 535–546.
15. Teraoka,S.N., Telatar,M., Becker-Catania,S., Liang,T., Onengut,S.,
Tolun,A., Chessa,L., Sanal,O., Bernatowska,E., Gatti,R.A. et al. (1999)
Splicing defects in the ataxia-telangiectasia gene, ATM: underlying
mutations and consequences. Am. J. Hum. Genet., 64, 1617–1631.
16. Lorson,C.L. and Androphy,E.J. (2000) An exonic enhancer is required
for inclusion of an essential exon in the SMA-determining gene SMN.
Hum. Mol. Genet., 9, 259–265.
17. Cartegni,L. and Krainer,A.R. (2002) Disruption of an
SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal
muscular atrophy in the absence of SMN1. Nature Genet., 30, 377–384.
18. Kashima,T. and Manley,J.L. (2003) A negative element in SMN2 exon
7 inhibits splicing in spinal muscular atrophy. Nature Genet., 34,
460–463.
19. Liu,H.X., Cartegni,L., Zhang,M.Q. and Krainer,A.R. (2001) A
mechanism for exon skipping caused by nonsense or missense
mutations in BRCA1 and other genes. Nature Genet., 27, 55–58.
20. Ars,E., Serra,E., Garcia,J., Kruyer,H., Gaona,A., Lazaro,C. and
Estivill,X. (2000) Mutations affecting mRNA splicing are the most
common molecular defects in patients with neurofibromatosis type 1.
Hum. Mol. Genet., 9, 237–247.
21. Pagani,F., Buratti,E., Stuani,C. and Baralle,F.E. (2003) Missense,
nonsense and neutral mutations define juxtaposed regulatory
elements of splicing in CFTR Exon 9. J. Biol. Chem., 278,
2680–2688.
22. Pagani,F., Stuani,C., Tzetis,M., Kanavakis,E., Efthymiadou,A.,
Doudounakis,S., Casals,T. and Baralle,F.E. (2003) New type of disease
causing mutations: the example of the composite exonic regulatory
elements of splicing in CFTR exon 12. Hum. Mol. Genet., 12,
1111–1120.
23. Aznarez,I., Chan,E.M., Zielenski,J., Blencowe,B.J. and Tsui,L.C.
(2003) Characterization of disease-associated mutations affecting an
exonic splicing enhancer and two cryptic splice sites in exon 13 of the
cystic fibrosis transmembrane conductance regulator gene. Hum. Mol.
Genet., 12, 2031–2040.
24. Chamary,J.V., Parmley,J.L. and Hurst,L.D. (2006) Hearing silence:
non-neutral evolution at synonymous sites in mammals. Nature Rev.
Genet., 7, 98–108.
25. Cartegni,L., Wang,J., Zhu,Z., Zhang,M.Q. and Krainer,A.R. (2003)
ESEfinder: A web resource to identify exonic splicing enhancers.
Nucleic Acids Res., 31, 3568–3571.
26. Zhang,X.H. and Chasin,L.A. (2004) Computational definition of
sequence motifs governing constitutive exon splicing. Genes Dev., 18,
1241–1250.
27. Webb,C.J., Romfo,C.M., van Heeckeren,W.J. and Wise,J.A. (2005)
Exonic splicing enhancers in fission yeast: functional conservation
demonstrates an early evolutionary origin. Genes Dev., 19,
242–254.
28. Pagani,F., Raponi,M. and Baralle,F.E. (2005) Synonymous mutations
in CFTR exon 12 affect splicing and are not neutral in evolution. Proc.
Natl Acad. Sci. USA, 102, 6368–6372.
29. Slomski,R., Schloesser,M., Berg,L.P., Wagner,M., Kakkar,V.V.,
Cooper,D.N. and Reiss,J. (1992) Omission of exon 12 in cystic fibrosis
transmembrane conductance regulator (CFTR) gene transcripts. Hum.
Genet., 89, 615–619.
30. Hull,J., Shackleton,S. and Harris,A. (1994) Analysis of mutations and
alternative splicing patterns in the CFTR gene using mRNA derived
from nasal epithelial cells. Hum Mol Genet, 3, 1141–1146.
31. Zielenski,J., Markiewicz,D., Lin,S.P., Huang,F.Y., Yang-Feng,T.L. and
Tsui,L.C. (1995) Skipping of exon 12 as a consequence of a point
mutation (1898 + 5G!T) in the cystic fibrosis transmembrane
conductance regulator gene found in a consanguineous Chinese family.
Clin. Genet., 47, 125–132.
32. Bremer,S., Hoof,T., Wilke,M., Busche,R., Scholte,B., Riordan,J.R.,
Maass,G. and Tummler,B. (1992) Quantitative expression patterns of
multidrug-resistance P-glycoprotein (MDR1) and differentially spliced
cystic-fibrosis transmembrane-conductance regulator mRNA
transcripts in human epithelia. Eur. J. Biochem., 206, 137–149.
33. Parmley,J.L., Chamary,J.V. and Hurst,L.D. (2006) Evidence for
purifying selection against synonymous mutations in mammalian
exonic splicing enhancers. Mol. Biol. Evol., 23, 301–309.
34. Meyer,I.M. and Miklos,I. (2005) Statistical evidence for conserved,
local secondary structure in the coding regions of eukaryotic mRNAs
and pre-mRNAs. Nucleic Acids Res., 33, 6338–6348.
35. Sorek,R., Shamir,R. and Ast,G. (2004) How prevalent is functional
alternative splicing in the human genome? Trends Genet., 20, 68–71.
36. Pagani,F., Buratti,E., Stuani,C., Romano,M., Zuccato,E., Niksic,M.,
Giglio,L., Faraguna,D. and Baralle,F.E. (2000) Splicing factors induce
cystic fibrosis transmembrane regulator exon 9 skipping through a
nonevolutionary conserved intronic element. J. Biol. Chem., 275,
21041–21047.
Nucleic Acids Research, 2007, Vol. 35, No. 2 613